{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:06:35Z","timestamp":1790096795195,"version":"4.0.1"},"reference-count":21,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2015,7,4]]},"DOI":"10.3109\/09546634.2014.991267","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T10:10:54Z","timestamp":1416996654000},"page":"326-328","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Inhibitors of phosphodiesterase 4 (PDE 4): A new therapeutic option in the treatment of psoriasis vulgaris and psoriatic arthritis"],"prefix":"10.1080","volume":"26","author":[{"given":"Ma\u0142gorzata","family":"Mazur","sequence":"first","affiliation":[{"name":"Department and Clinic of Dermatology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Karczewski","sequence":"additional","affiliation":[{"name":"Laboratory of Transplantation Immunology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Lodyga","sequence":"additional","affiliation":[{"name":"Department and Clinic of Dermatology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"\u017baba","sequence":"additional","affiliation":[{"name":"Department and Clinic of Dermatology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland,"},{"name":"Department of Dermatology and Venereology, Faculty of Health Sciences, Karol Marcinkowski University of Medical Sciences, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zygmunt","family":"Adamski","sequence":"additional","affiliation":[{"name":"Department and Clinic of Dermatology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland,"},{"name":"Department of Dermatology and Venereology, Faculty of Health Sciences, Karol Marcinkowski University of Medical Sciences, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,12,29]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.01.001"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.064691"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jlb.63.1.101","volume":"63","author":"Eigler A","year":"1998","journal-title":"J Leukoc Biol."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2008-0091TR"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12371679"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-011-1036-6"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.10.064"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S32713"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.05.014"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00559.x"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04716.x"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60642-4"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-82"},{"key":"CIT0014","unstructured":"Reich K, Papp K, Leonardi C, et al. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe psoriasis: 16-week results of a phase 3, randomized, controlled trial (ESTEEM 1) [oral presentation]. Annual meeting of the American Academy of Dermatology, Miami, 2013"},{"key":"CIT0015","unstructured":"Papp K, Reich K, Leonardi C, et al. Apremilast, an oral phosphodiesterase 4 inhibitor in nail and scalp psoriasis: 52-week results from the ESTEEM 1 study [abstract P1601]. Annual Congress of the European Academy of Dermatology and Venereology, Istanbul; 2013"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.699959"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121200"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1002\/art.34627"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1002\/art.34436"},{"key":"CIT0020","unstructured":"Celgene International Sarl. Apremilast achieves statistical significance for the primary endpoint of the first phase III study (PALACE-1) in patients with psoriatic arthritis [press release]; 2012. Available from http:\/\/ir.celgene.com\/phoenix.zhtml?c=111960&p=irol-newsArticle&ID=1714113&highlight=. Accessed August 6, 2013"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0218-4"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/09546634.2014.991267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T19:10:12Z","timestamp":1661195412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/09546634.2014.991267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,29]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7,4]]}},"alternative-id":["10.3109\/09546634.2014.991267"],"URL":"https:\/\/doi.org\/10.3109\/09546634.2014.991267","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-08-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-10-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}